CCND1 and breast cancer: Combinatorial administration of estrogen, tamoxifen and genistein increased proliferation, decreased apoptosis, increased the levels of cyclin D1 and progesterone receptors mRNA, suggesting that genistein consumption should be recommended with precaution in breast cancer patients receiving tamoxifen [246].